浙江预防医学
浙江預防醫學
절강예방의학
ZHEJIANG JOURNAL OF PREVENTIVE MEDICINE
2014年
3期
233-236
,共4页
结核病%耐药性%监测
結覈病%耐藥性%鑑測
결핵병%내약성%감측
Tuberculosis%Pulmonary%Drug resistance
目的:分析湖州市实施现行结核病控制策略对耐药变迁状况的影响。方法收集2001-2004年(第1次监测)和2009年7月-2010年6月(第2次监测)湖州市各县(市、区)结核病新登记痰培养阳性并鉴定为结核分枝杆菌的结核病患者标本192和772份,培养阳性菌株标本做药敏试验,药敏试验采用比例法。结果第1次监测与第2次监测相比,总耐药率由25.25%下降至15.41%,差异有统计学意义(P<0.01);总耐多药率由6.88%下降至3.50%,差异有统计学意义(P<0.01);获得性耐药率自51.30%下降至43.02%,差异无统计学意义(P>0.05);初始耐药率由19.02%下降至11.95%,差异有统计学意义(P<0.01)。结论现行结核病控制策略实施下,结核病耐药率有所下降。
目的:分析湖州市實施現行結覈病控製策略對耐藥變遷狀況的影響。方法收集2001-2004年(第1次鑑測)和2009年7月-2010年6月(第2次鑑測)湖州市各縣(市、區)結覈病新登記痰培養暘性併鑒定為結覈分枝桿菌的結覈病患者標本192和772份,培養暘性菌株標本做藥敏試驗,藥敏試驗採用比例法。結果第1次鑑測與第2次鑑測相比,總耐藥率由25.25%下降至15.41%,差異有統計學意義(P<0.01);總耐多藥率由6.88%下降至3.50%,差異有統計學意義(P<0.01);穫得性耐藥率自51.30%下降至43.02%,差異無統計學意義(P>0.05);初始耐藥率由19.02%下降至11.95%,差異有統計學意義(P<0.01)。結論現行結覈病控製策略實施下,結覈病耐藥率有所下降。
목적:분석호주시실시현행결핵병공제책략대내약변천상황적영향。방법수집2001-2004년(제1차감측)화2009년7월-2010년6월(제2차감측)호주시각현(시、구)결핵병신등기담배양양성병감정위결핵분지간균적결핵병환자표본192화772빈,배양양성균주표본주약민시험,약민시험채용비례법。결과제1차감측여제2차감측상비,총내약솔유25.25%하강지15.41%,차이유통계학의의(P<0.01);총내다약솔유6.88%하강지3.50%,차이유통계학의의(P<0.01);획득성내약솔자51.30%하강지43.02%,차이무통계학의의(P>0.05);초시내약솔유19.02%하강지11.95%,차이유통계학의의(P<0.01)。결론현행결핵병공제책략실시하,결핵병내약솔유소하강。
Objective To obtain the data on total drug resistance rate,initial drug resistant rate and acquired drug resistant rate and to analyze the efficacy of modern tuberculosis control strategy in Huzhou City.Methods Collect sputum specimens which were cultured positive from mycobacterium tuberculosis patients with new registration and identification in Huzhou in the first stage (2001-2004)and second stage (2009-2010).The sample size was 192 and 772 respectively. We used cultured positive specimens for drug sensitivity test which was by means of proportion method.Results In the first stage (2001-2004 ),the rate of total drug resistance,multi -drug resistance,initial resistance and acquired resistance was 25.25%,6.9%,19.02% and 51.30% respectively.The rates above in the second stage (2009-2010) were 15.41%,3.50%,1 1.95% and 43.02% respectively.There was significant difference (P<0.01 )in the rates of total drug resistance,multi-drug resistance and initial resistance between the two stages,but no significant difference (P>0.05 ) in the rate of acquired resistance. Conclusion Modern tuberculosis control strategy makes noticeable achievements for the drug resistant tuberculosis control,but the acquired drug resistance remains to be the focus of tuberculosis prevention and control in the current strategy.